Sequoia Genetics

Founded in 2024, Sequoia Genetics is a private limited company that works with academia, investors, pharma and biotech by performing research that leverages genetic data to help inform drug discovery and development. Our team is made up of biologists, clinicians, epidemiologists, statisticians, data scientists, bioinformaticians and industry experts that have collectively published hundreds of research papers in the field and are vastly experienced in translating genetic insights to guide clinical development decisions. At Sequoia Genetics, we are committed to transforming the drug development paradigm by optimizing the translation of insights from genetic data. We aim to foster a culture of transparency, inclusivity, and continuous improvement, empowering our clients to achieve breakthroughs in science and healthcare. Inspired by resilience, self-improvement, and social justice, we strive to be a catalyst for positive change in the drug development industry.